tradmap

PACB Pacific Biosciences Of California, Inc.

$1.39 +3.35%

Healthcare · Laboratory Analytical Instruments

Pacific Biosciences Of California, Inc. (PACB) is a healthcare company in the Laboratory Analytical Instruments industry, with a market capitalization of $432 million. Shares last traded at $1.39, 49.1% below their 52-week high. Over the past year the stock is up 6.9%. Net profit margin is -341.5%, below the peer median of -1.5%. Revenue grew 3.9% year over year.

Market Cap
$432M
Shares Out
310.6M
EPS (TTM)
$-4.73
P/E Ratio
P/S Ratio
2.70
P/B Ratio
182.48
Dividend / Share
Dividend Yield
52-Week High
$2.73
52-Week Low
$1.09
Volume
167,048
Avg Vol (3m)
278,180.889

Performance

1W
+2.96%
1M
+20.87%
3M
-1.07%
6M
-30.85%
YTD
-24.86%
1Y
+6.92%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
49.78
SMA (50)
$1.45
SMA (200)
$1.68
Price vs SMA50
-3.96%
Price vs SMA200
-17.38%
ATR (14)
$0.11

Financials

Revenue
$160M
Net Income
$-546M
Gross Margin
28.6%
Operating Margin
-346.2%
Net Margin
-341.5%
Return on Equity
-23093.8%
Return on Assets
-69.8%
Current Ratio
5.65
Debt / Equity
379.05
Revenue Growth (YoY)
+3.9%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

PeriodEPS (diluted)Reported
Q1 2026 $-0.03 2026-05-08
FY 2025 $-1.82 2026-02-25
Q3 2025 $-1.69 2025-11-06
Q2 2025 $-1.57 2025-08-07
Q1 2026 $-1.44 2026-05-08
FY 2025 $-1.59 2026-02-25

Full earnings history →

Laboratory Analytical Instruments peers

PACB vs 14 industry peers (Laboratory Analytical Instruments), by market cap.

P/S vs peers
2.70 / 2.95 med
-8% discount
Net margin vs peers
-341.5% / -1.5% med
below median
1–14 of 14
AAgilent Technologies$35.9B27.555.1718.8%+2.23%
WATWaters Corporation$34.9B54.3211.0320.3%-0.44%
ILMNIllumina, Inc.$24.5B28.805.6419.6%+1.68%
MTDMettler Toledo$23.1B26.595.7421.6%+1.22%
RVTYRevvity$11.1B46.223.908.4%+2.23%
BRKRBruker Corp$8.7B-1049.062.53-0.2%+4.51%
BIOBio-Rad Laboratories, Inc.$7.6B10.022.9529.4%-0.80%
AVTRAvantor, Inc.$6.5B-12.321.00-8.1%+1.16%
TXG10x Genomics, Inc.$4.5B-102.516.94-6.8%+8.24%
ALMRAlamar Biosciences, Inc.$1.5B+8.56%
EYPTEyepoint, Inc.$1.1B-4.91+3.35%
CTKBCytek Biosciences, Inc.$488M-7.342.42-33.0%-4.91%
PACBPacific Biosciences Of California, Inc.$432M-0.79+3.35%
LABSTANDARD BIOTOOLS INC.$324M-4.323.79-87.8%+2.65%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.